English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer
2009 ASCO Annual Meeting
29 May - 2 Jun 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
17 Jun 2009
Views:
13186
Rating:
Save
Rate video
Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US
ASCO press conference: Adding bevacizumab (avastin) to standard adjuvant chemotherapy does not improve disease-free survival for early-stage colon cancer
Categories:
Colorectal & gastro
Related Videos
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy...
Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA
26 Jan 2023
HER-Vaxx is safe and provides clinical benefit over standard of care chemo for...
Dr Tanuj Chawla and Dr Giovanni Selvaggi
25 Jan 2023
Zolbetuximab + mFOLFOX6 as 1L treatment shows significantly prolonged PFS and...
Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan
25 Jan 2023
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates...
Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA
25 Jan 2023
OPERA: Nonoperative modality (NOM) treatments of rectal cancer do not...
Prof Arthur Sun Myint - Clatterbridge Cancer Centre, Clatterbridge, UK
25 Jan 2023
NIVO + chemo and NIVO + IPI continue to demonstrate clinically meaningful...
Dr Ken Kato - National Cancer Center Hospital, Tokyo, Japan
25 Jan 2023
Epidemiology, detection, and management of NAFLD: a Latin American perspective
Dr Nahum Mendez-Sanchez - National Autonomous University of Mexico, Mexico City...
20 Dec 2022
Genomic testing in biliary tract cancers
Dr Chiara Braconi - University of Glasgow, Glasgow, UK
24 Oct 2022
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
25 Sep 2022
More from
e
cancer